137 related articles for article (PubMed ID: 22675838)
1. QT variability in amyloidosis of familial Mediterranean fever.
Nussinovitch U; Ben-Zvi I; Livneh A
Isr Med Assoc J; 2012 Apr; 14(4):225-8. PubMed ID: 22675838
[TBL] [Abstract][Full Text] [Related]
2. Familial Mediterranean Fever is associated with abnormal ventricular repolarization indices.
Ahbap E; Sakaci T; Kara E; Sahutoglu T; Ozturk S; Basturk T; Koc Y; Sevinc M; Akgol C; Ucar ZA; Kayalar AO; Caglayan FB; Gurbuz S; Unsal A
Rev Med Chil; 2015 Dec; 143(12):1560-8. PubMed ID: 26928618
[TBL] [Abstract][Full Text] [Related]
3. Esophageal motor function in Familial Mediterranean Fever: a prospective evaluation of motility in 31 patients.
Bektaş M; Doğanay B; Alkan M; Ustun Y; Soykan I
Eur J Intern Med; 2009 Sep; 20(5):548-50. PubMed ID: 19712864
[TBL] [Abstract][Full Text] [Related]
4. Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever.
Nussinovitch U; Volovitz B; Nussinovitch M; Lidar M; Feld O; Nussinovitch N; Livneh A
Amyloid; 2011 Dec; 18(4):206-10. PubMed ID: 22080764
[TBL] [Abstract][Full Text] [Related]
5. QT dispersion in amyloidosis due to familial Mediterranean fever.
Nussinovitch U; Nussinovitch N; Nussinovitch M; Volovitz B; Feld O; Ben-Zvi I; Livneh A
Rheumatol Int; 2012 Jul; 32(7):1945-8. PubMed ID: 21461715
[TBL] [Abstract][Full Text] [Related]
6. QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients.
Nussinovitch U; Kaminer K; Nussinovitch M; Volovitz B; Lidar M; Nussinovitch N; Livneh A
Clin Rheumatol; 2012 May; 31(5):795-9. PubMed ID: 22271228
[TBL] [Abstract][Full Text] [Related]
7. QT variability among weight-restored patients with anorexia nervosa.
Nussinovitch M; Gur E; Kaminer K; Volovitz B; Nussinovitch N; Nussinovitch U
Gen Hosp Psychiatry; 2012; 34(1):62-5. PubMed ID: 21831447
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment.
Canpolat U; Dural M; Aytemir K; Akdoğan A; Kaya EB; Sahiner L; Yalçin U; Canpolat AG; Calgüneri M; Kabakçi G; Tokgözoğlu L; Oto A
Auton Neurosci; 2012 Apr; 167(1-2):70-4. PubMed ID: 22104493
[TBL] [Abstract][Full Text] [Related]
9. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
10. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroglu IC; Calgüneri M; Atalar E; Ozbalkan Z; Kirazli S; Celik I
J Rheumatol; 2003 Feb; 30(2):313-5. PubMed ID: 12563687
[TBL] [Abstract][Full Text] [Related]
11. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.
Piccirillo G; Germanò G; Quaglione R; Nocco M; Lintas F; Lionetti M; Moisè A; Ragazzo M; Marigliano V; Cacciafesta M
Clin Sci (Lond); 2002 Mar; 102(3):363-71. PubMed ID: 11869178
[TBL] [Abstract][Full Text] [Related]
12. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
13. QT dispersion in uncomplicated familial Mediterranean fever.
Nussinovitch N; Livneh A; Katz K; Langevitz P; Feld O; Nussinovitch M; Volovitz B; Lidar M; Nussinovitch U
Clin Rheumatol; 2010 Dec; 29(12):1353-6. PubMed ID: 20383732
[TBL] [Abstract][Full Text] [Related]
14. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
[TBL] [Abstract][Full Text] [Related]
15. Cardiac repolarization abnormalities in children with familial Mediterranean fever.
Farag Y; Sayed S; Mostafa FA; Marzouk H; Mohamed RH; Sobhy R
Pediatr Rheumatol Online J; 2022 May; 20(1):38. PubMed ID: 35606812
[TBL] [Abstract][Full Text] [Related]
16. [Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].
Livneh A
Harefuah; 2006 Oct; 145(10):743-5, 782. PubMed ID: 17111710
[TBL] [Abstract][Full Text] [Related]
17. Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF).
Nussinovitch U; Livneh A; Volovitz B; Nussinovitch M; Ben-Zvi I; Lidar M; Nussinovitch N
Clin Rheumatol; 2012 Jul; 31(7):1093-6. PubMed ID: 22526475
[TBL] [Abstract][Full Text] [Related]
18. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
Nadir H; Unver S; Ozel AM; Yazgan Y; Gultepe M; Evrenkaya TR; Demirturk L; Gurbuz AK
Ren Fail; 2007; 29(1):73-7. PubMed ID: 17365913
[TBL] [Abstract][Full Text] [Related]
19. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease.
Ozel Demiralp D; Ekim M; Akar N
Clin Appl Thromb Hemost; 2009; 15(4):443-7. PubMed ID: 19033264
[TBL] [Abstract][Full Text] [Related]
20. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.
Stankovic Stojanovic K; Delmas Y; Torres PU; Peltier J; Pelle G; Jéru I; Colombat M; Grateau G
Nephrol Dial Transplant; 2012 May; 27(5):1898-901. PubMed ID: 21931121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
